DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Acosta A, Camilleri M, Shin A. et al.
Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome.
Clin Transl Gastroenterol 2016;
7: e173 doi: 10.1038/ctg.2016.32
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.